MGC Pharmaceuticals Ltd (MXC) is a publicly traded drug manufacturers-specialty and generic business based in Australia. It opened the day at A$0.016 after a previous close of A$0.015. During the day the price has varied from a low of A$0.015 to a high of A$0.016. The latest price was A$0.015 (25 minute delay). MGC Pharmaceuticals is listed on the Australian Securities Exchange (ASX). All prices are listed in Australian Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
Index funds
Historical closes compared with the last close of A$0.015
| 1 week (2022-09-27) | -3.23% |
|---|---|
| 1 month (2022-09-02) | -6.25% |
| 3 months (2022-07-04) | -16.67% |
| 6 months (2022-04-04) | -37.50% |
| 1 year (2021-10-04) | -73.68% |
|---|---|
| 2 years (2020-10-02) | -34.78% |
| 3 years (2019-10-04) | -59.46% |
| 5 years (2017-10-04) | -61.54% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
| Open | A$0.016 |
|---|---|
| High | A$0.016 |
| Low | A$0.015 |
| Close | A$0.015 |
| Previous close | A$0.015 |
| Change | A$0 |
| Change % | 0% |
| Volume | 1,668,311 |
| 52-week range | A$0.015 - A$0.062 |
|---|---|
| 50-day moving average | A$0.0177 |
| 200-day moving average | A$0.0243 |
| Wall St. target price | A$0.07 |
| PE ratio | 0 |
| Dividend yield | A$0 (0%) |
| Earnings per share (TTM) | A$-0.008 |
We're not expecting MGC Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, MGC Pharmaceuticals's shares have ranged in value from as little as A$0.015 up to A$0.062. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while MGC Pharmaceuticals's is 1.7147. This would suggest that MGC Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Our Minuts review looks at the features, customer reviews, fees, learning resources and some pros and cons of investing with Mintus
Thinking about buying shares in Flex LNG? We explain how to do it and compare a range of providers who will give you access to global markets.
Everything we know about the Corebridge Financial IPO, plus information on how to buy shares.
GreenGrowth is a brand new ethical investment platform that creates a portfolio for you based on your carbon footprint. See what we thought.
Investing in art could be a nice way to animate your investment portfolio with an alternative asset. Here’s how it works and the risks.
We explain the different account types that you’ll come across when signing up with an investment platform.
Everything we know about the Hempacco IPO, plus information on how to buy shares.
Everything we know about the Jianzhi Education Technology Group IPO, plus information on how to buy shares.
Find out the best time to invest in stocks, the risks involved, plus a range of different strategies to consider when investing.
Discover how a bear market works and why it’s important for long term investors to sit tight and not to panic.